Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)

Detalles Bibliográficos
Autores principales: Boschi, Céline, Colson, Philippe, Bancod, Audrey, Moal, Valérie, La Scola, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402686/
https://www.ncbi.nlm.nih.gov/pubmed/35171987
http://dx.doi.org/10.1093/cid/ciac143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402686/
https://www.ncbi.nlm.nih.gov/pubmed/35171987
http://dx.doi.org/10.1093/cid/ciac143

Ejemplares similares